RXi Pharmaceuticals Corporation (RXII) dipped -10.28% or -0.37 to $3.23. It is near 46948 shares traded, which is 60.53% compare to the average total volume 77561. The market cap of RXII is $765423. The year to date change is -34.55%. The 52 week price range is from $3.2 to $11.2. Price of RXII have changed -13.25% during last week. It have changed -23.21% over last month, -38.96% over last 3 months, -36.84% over last 6 months and -43.63% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 5.26. It is 62.85% above current price. The 200-day Moving Averages for RXII is 5.65. It is 74.92% above current price. The 52-week High is 11.2. It is 246.75% from the current price. The 52-week Low is 3.2. It is -0.93% from current price.
There are some statistics of RXII. It is has market cap $765423. The share outstanding is 236973. The average volume is 77561. The percent of top 15 Institution holding is 0.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -459.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -271.89%.